We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.1B
AUM Growth
+$282M
Cap. Flow
+$321M
Cap. Flow %
15.28%
Top 10 Hldgs %
31.03%
Holding
185
New
43
Increased
48
Reduced
68
Closed
26

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$37.3M
2
SON icon
Sonoco
SON
+$27.1M
3
MTCH icon
Match Group
MTCH
+$24.8M
4
PLD icon
Prologis
PLD
+$23.9M
5
SLB icon
SLB Ltd
SLB
+$19.3M

Top Sells

Rank Stock Value
1
MTB icon
M&T Bank
MTB
+$36.8M
2
ZM icon
Zoom
ZM
+$25.3M
3
WBD icon
Warner Bros
WBD
+$23.6M
4
LYFT icon
Lyft
LYFT
+$22.3M
5
EXPE icon
Expedia Group
EXPE
+$20.5M

Sector Composition

Rank Sector Weight
1 Technology 18.46%
2 Consumer Discretionary 13.65%
3 Healthcare 10.33%
4 Communication Services 7.49%
5 Consumer Staples 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$445B
$192M 9.12%
+375,000
New +$190M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$117M 5.58%
+200,000
New +$118M
GPN icon
3
Global Payments
GPN
$23.9B
$60M 2.86%
535,454
-146,803
-22% -$16.1M
XRAY icon
4
Dentsply Sirona
XRAY
$2.7B
$50.1M 2.38%
2,639,161
+1,762,428
+201% +$37.3M
ES icon
5
Eversource Energy
ES
$28.4B
$48.8M 2.32%
849,698
+223,050
+36% +$13.9M
VTRS icon
6
Viatris
VTRS
$20.8B
$40.6M 1.93%
3,260,431
-499,112
-13% -$6.13M
TAP icon
7
Molson Coors Class B
TAP
$7.97B
$37.4M 1.78%
652,121
+132,744
+26% +$7.74M
CHRD icon
8
Chord Energy
CHRD
$7.25B
$36.6M 1.74%
313,246
+49,906
+19% +$6.27M
MTCH icon
9
Match Group
MTCH
$9.16B
$36.2M 1.72%
1,106,876
+724,818
+190% +$24.8M
CLVT icon
10
Clarivate
CLVT
$1.53B
$33.5M 1.59%
6,585,707
+667,146
+11% +$3.84M
SON icon
11
Sonoco
SON
$5.99B
$32.6M 1.55%
666,430
+524,198
+369% +$27.1M
AKAM icon
12
Akamai
AKAM
$16.3B
$32.3M 1.54%
338,089
+162,105
+92% +$15.9M
T icon
13
AT&T
T
$169B
$30M 1.43%
1,315,793
-213,327
-14% -$4.8M
CNXC icon
14
Concentrix
CNXC
$1.55B
$28.8M 1.37%
666,433
+194,190
+41% +$8.64M
ST icon
15
Sensata Technologies
ST
$6.8B
$28.6M 1.36%
1,044,180
+186,511
+22% +$6.06M
SSNC icon
16
SS&C Technologies
SSNC
$18.8B
$28M 1.33%
369,861
-59,632
-14% -$4.46M
PGNY icon
17
Progyny
PGNY
$2.41B
$28M 1.33%
1,622,129
-138,577
-8% -$2.15M
OVV icon
18
Ovintiv
OVV
$16.4B
$27M 1.28%
665,671
-101,414
-13% -$4.22M
LYFT icon
19
Lyft
LYFT
$5.87B
$26.4M 1.26%
2,048,165
-1,501,795
-42% -$22.3M
ZM icon
20
Zoom
ZM
$26.8B
$23.7M 1.13%
289,926
-321,793
-53% -$25.3M
FIVE icon
21
Five Below
FIVE
$11.5B
$23.3M 1.11%
222,401
+23,281
+12% +$2.23M
NOMD icon
22
Nomad Foods
NOMD
$1.7B
$23M 1.09%
1,368,763
-163,946
-11% -$2.86M
DNB
23
DELISTED
Dun & Bradstreet
DNB
$22.6M 1.07%
1,812,722
-378,078
-17% -$4.52M
PLD icon
24
Prologis
PLD
$137B
$22M 1.05%
+207,979
New +$23.9M
SOLV icon
25
Solventum
SOLV
$14.9B
$21.2M 1.01%
320,609
-264,274
-45% -$18.5M
1
2 3 4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Invenomic Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Invenomic Capital Management held 185 positions worth $2.1B, up 15% from $1.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Invenomic Capital Management deployed $321M of net new capital in Q4 2024, opening 43 new positions and adding to 48 existing holdings. Its largest new stake was Prologis: 207,979 shares worth $22M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was M&T Bank, an estimated $36.8M trimmed.

  • Invenomic Capital Management's largest Q4 2024 buy was Prologis: 207,979 shares worth $22M.
  • Invenomic Capital Management added most to Dentsply Sirona in Q4 2024, an estimated $37.3M increase.
  • Invenomic Capital Management's biggest Q4 2024 reduction was M&T Bank, cutting an estimated $36.8M.
  • Invenomic Capital Management fully exited Warner Bros in Q4 2024, selling an estimated $23.6M.
  • Invenomic Capital Management's ten largest holdings make up 31% of its $2.1B portfolio in Q4 2024.
  • Invenomic Capital Management opened 43 new positions and closed 26 in Q4 2024.
  • Invenomic Capital Management's portfolio value rose 15% quarter-over-quarter to $2.1B.

Based on Invenomic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.